0001628280-26-034381
SEC filingRevenue more than doubled to $6.5M on commercial traction, driving gross profit growth to $2.7M at 41% margin, though operating losses widened to -$2.3M from higher professional services and headcount costs, narrowing net loss to -$3.4M via warrant liability gains amid persistent cash burn.
QT Imaging achieved 133% YoY revenue growth to $6.5M from $2.8M in Q1 FY2026, demonstrating accelerating adoption of its Breast Acoustic CT Scanner. This topline expansion underscores successful distribution ramp-up and market validation for the radiation-free imaging technology, positioning the company to capture share in breast diagnostics. Investors should monitor scanner utilization and partnership renewals as key sustainment signals.
Gross profit increased 47.5% to $2.7M, yielding a 40.9% margin versus prior period. The improvement reflects higher revenue volumes outpacing cost of revenue growth. Management notes expectations for cost of revenue to rise in absolute dollars but decline as a percentage over time, driven by shifts to efficient manufacturing processes and vendors. This trajectory supports operating leverage potential as production scales.
Net cash used in operations was -$3.7M, yielding free cash flow of -$3.7M after minimal $17K capex. Ongoing burn funds scanner development and market entry, consistent with pre-profitability phase. The company acknowledges needing significant additional revenue to offset rising expenses and sustain operations, potentially requiring further capital raises.
Management anticipates substantial R&D increases for Breast Acoustic CT Scanner advancement, alongside cost of revenue optimization via new processes. Risk factors highlight geopolitical threats like Strait of Hormuz disruptions, which could elevate energy prices and logistics costs for petroleum-based materials. No quantitative guidance is provided, but emphasis on manufacturing partnerships signals 2026 efficiency inflection.